These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 8573610

  • 1. Development and analysis of retroviral vectors expressing human factor VIII as a potential gene therapy for hemophilia A.
    Chuah MK, VandenDriessche T, Morgan RA.
    Hum Gene Ther; 1995 Nov; 6(11):1363-77. PubMed ID: 8573610
    [Abstract] [Full Text] [Related]

  • 2. Bone marrow stromal cells as targets for gene therapy of hemophilia A.
    Chuah MK, Brems H, Vanslembrouck V, Collen D, VandenDriessche T.
    Hum Gene Ther; 1998 Feb 10; 9(3):353-65. PubMed ID: 9508053
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Bone marrow mesenchymal cells for haemophilia A gene therapy using retroviral vectors with modified long-terminal repeats.
    Van Damme A, Chuah MK, Dell'accio F, De Bari C, Luyten F, Collen D, VandenDriessche T.
    Haemophilia; 2003 Jan 10; 9(1):94-103. PubMed ID: 12558785
    [Abstract] [Full Text] [Related]

  • 5. Sequences in the coding region of clotting factor VIII act as dominant inhibitors of RNA accumulation and protein production.
    Lynch CM, Israel DI, Kaufman RJ, Miller AD.
    Hum Gene Ther; 1993 Jun 10; 4(3):259-72. PubMed ID: 8338874
    [Abstract] [Full Text] [Related]

  • 6. [Retroviral-mediated high efficient in vitro expression of human coagulation factor VIII].
    Guo X, Wang H, Chu H, Wang X, Qu B, Li Z, Qi Z, Wang Z.
    Zhonghua Xue Ye Xue Za Zhi; 2000 Sep 10; 21(9):457-9. PubMed ID: 11877017
    [Abstract] [Full Text] [Related]

  • 7. High level expression of human factor VIII in mammalian cells after retroviral-mediated gene transfer.
    Guo X, Wang H, Chu H, Wang X, Qu B, Li Z, Qi Z, Wang Z.
    Chin Med J (Engl); 2001 Jul 10; 114(7):690-3. PubMed ID: 11780328
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Human factor VIII expression in retrovirus vector-transduced bone marrow stromal cells].
    Guo X, Wang H, Chu H.
    Zhonghua Xue Ye Xue Za Zhi; 2001 Sep 10; 22(9):461-3. PubMed ID: 11758224
    [Abstract] [Full Text] [Related]

  • 11. Induction of tolerance to factor VIII inhibitors by gene therapy with immunodominant A2 and C2 domains presented by B cells as Ig fusion proteins.
    Lei TC, Scott DW.
    Blood; 2005 Jun 15; 105(12):4865-70. PubMed ID: 15769892
    [Abstract] [Full Text] [Related]

  • 12. Production of human factor VIII-FL in 293T cells using the bicistronic MGMT(P140K)-retroviral vector.
    Fontes AM, Melo FU, Greene LJ, Faça VM, Lin Y, Gerson SL, Covas DT.
    Genet Mol Res; 2012 Mar 22; 11(1):775-89. PubMed ID: 22576836
    [Abstract] [Full Text] [Related]

  • 13. Sustained human factor VIII expression in hemophilia A mice following systemic delivery of a gutless adenoviral vector.
    Reddy PS, Sakhuja K, Ganesh S, Yang L, Kayda D, Brann T, Pattison S, Golightly D, Idamakanti N, Pinkstaff A, Kaloss M, Barjot C, Chamberlain JS, Kaleko M, Connelly S.
    Mol Ther; 2002 Jan 22; 5(1):63-73. PubMed ID: 11786047
    [Abstract] [Full Text] [Related]

  • 14. In vivo gene delivery and expression of physiological levels of functional human factor VIII in mice.
    Connelly S, Smith TA, Dhir G, Gardner JM, Mehaffey MG, Zaret KS, McClelland A, Kaleko M.
    Hum Gene Ther; 1995 Feb 22; 6(2):185-93. PubMed ID: 7537539
    [Abstract] [Full Text] [Related]

  • 15. Gene therapy for hemophilia A: production of therapeutic levels of human factor VIII in vivo in mice.
    Dwarki VJ, Belloni P, Nijjar T, Smith J, Couto L, Rabier M, Clift S, Berns A, Cohen LK.
    Proc Natl Acad Sci U S A; 1995 Feb 14; 92(4):1023-7. PubMed ID: 7862626
    [Abstract] [Full Text] [Related]

  • 16. Characteristics of Minimally Oversized Adeno-Associated Virus Vectors Encoding Human Factor VIII Generated Using Producer Cell Lines and Triple Transfection.
    Nambiar B, Cornell Sookdeo C, Berthelette P, Jackson R, Piraino S, Burnham B, Nass S, Souza D, O'Riordan CR, Vincent KA, Cheng SH, Armentano D, Kyostio-Moore S.
    Hum Gene Ther Methods; 2017 Feb 14; 28(1):23-38. PubMed ID: 28166648
    [Abstract] [Full Text] [Related]

  • 17. Absence of a desmopressin response after therapeutic expression of factor VIII in hemophilia A dogs with liver-directed neonatal gene therapy.
    Xu L, Nichols TC, Sarkar R, McCorquodale S, Bellinger DA, Ponder KP.
    Proc Natl Acad Sci U S A; 2005 Apr 26; 102(17):6080-5. PubMed ID: 15837921
    [Abstract] [Full Text] [Related]

  • 18. Long-term persistence of human bone marrow stromal cells transduced with factor VIII-retroviral vectors and transient production of therapeutic levels of human factor VIII in nonmyeloablated immunodeficient mice.
    Chuah MK, Van Damme A, Zwinnen H, Goovaerts I, Vanslembrouck V, Collen D, VandenDriessche T.
    Hum Gene Ther; 2000 Mar 20; 11(5):729-38. PubMed ID: 10757352
    [Abstract] [Full Text] [Related]

  • 19. Complete correction of hemophilia A with adeno-associated viral vectors containing a full-size expression cassette.
    Lu H, Chen L, Wang J, Huack B, Sarkar R, Zhou S, Xu R, Ding Q, Wang X, Wang H, Xiao W.
    Hum Gene Ther; 2008 Jun 20; 19(6):648-54. PubMed ID: 18500941
    [Abstract] [Full Text] [Related]

  • 20. Onco-retroviral and lentiviral vector-based gene therapy for hemophilia: preclinical studies.
    Van Damme A, Chuah MK, Collen D, VandenDriessche T.
    Semin Thromb Hemost; 2004 Apr 20; 30(2):185-95. PubMed ID: 15118930
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.